Interim effect evaluation of the hepatitis C elimination programme in Georgia: a modelling study

Autor: Josephine G Walker, PhD, Tinatin Kuchuloria, MD, David Sergeenko, MD, Hannah Fraser, PhD, Aaron G Lim, DPhil, Shaun Shadaker, MPH, Liesl Hagan, MPH, Amiran Gamkrelidze, ProfPhD, Valeri Kvaratskhelia, MD, Lia Gvinjilia, MD, Malvina Aladashvili, MD, Alexander Asatiani, MD, Davit Baliashvili, MD, Maia Butsashvili, ProfPhD, Ivdity Chikovani, MD, Irma Khonelidze, MD, Irma Kirtadze, PhD, Mark H Kuniholm, PhD, David Otiashvili, PhD, Lali Sharvadze, PhD, Ketevan Stvilia, MD, Tengiz Tsertsvadze, ProfPhD, Mamuka Zakalashvili, MD, Matthew Hickman, PhD, Natasha K Martin, DPhil, Juliette Morgan, MD, Muazzam Nasrullah, PhD, Francisco Averhoff, MD, Peter Vickerman, ProfDPhil

Publikováno v: The Lancet Global Health, Vol 8, Iss 2, Pp e244-e253 (2020)

Summary: Background: Georgia has a high prevalence of hepatitis C, with 5·4% of adults chronically infected. On April 28, 2015, Georgia launched a national programme to eliminate hepatitis C by 2020 (90% reduction in prevalence) through scaled-up tr

Externí odkaz: https://doaj.org/article/3bc3fb73a00649c1884f1f75f9adb138

Retreatment of Chronic Hepatitis C Infection: Real-World Regimens and Outcomes From National Treatment Programs in Three Low- and Middle-Income Countries

Autor: Neil Gupta, Imam Waked, Lindsey Hiebert, Maia Butsashvili, Christian B Ramers, John W. Ward, Win Naing, Caroline E. Boeke, Fredrick Kateera, Craig McClure, Lali Sharvadze, Tengiz Tsertsvadze, Mamuka Zakalashvili

Publikováno v: Clinical Infectious Diseases. 74:513-516

Access to recommended second-line treatments is limited for patients who fail initial hepatitis C virus (HCV) therapy in low- and middle-income countries. Alternative regimens and associated outcomes are not well understood. Through a pooled analysis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38c88b53678be933a4883ff9f4338f44
https://doi.org/10.1093/cid/ciab461

Assessment of treatment options for patients with hepatitis C virus recombinant form 2k/1b

Autor: Mamuka Zakalashvili, Sophia Metreveli, Jaba Zarkua, Lia Gvinjilia, Maia Zhamutashvili, Vakhtang Sartania, David Metreveli, Robert G. Gish, Nikoloz Abramishvili, Irakli Rtskhiladze, Monika Raabe, Michael Weizenegger, Maka Barnova, Jan Bartel

Publikováno v: Hepatology research : the official journal of the Japan Society of HepatologyReferences. 51(2)

AIM Hepatitis C virus (HCV) intergenotype recombinant form (RF) 2k/1b has been actively circulating in HCV-infected patients, and the prevalence of this RF virus in the Republic of Georgia is one of the highest reported worldwide. The aim of this stu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b7ea19b823725531fcb8667c2ea11b4
https://pubmed.ncbi.nlm.nih.gov/33207029

Interim effect evaluation of the hepatitis C elimination programme in Georgia: a modelling study

Autor: Lia Gvinjilia, Muazzam Nasrullah, Liesl Hagan, Amiran Gamkrelidze, V. Kvaratskhelia, Malvina Aladashvili, David Sergeenko, Peter Vickerman, Tengiz Tsertsvadze, Natasha K. Martin, D. Baliashvili, Ivdity Chikovani, Maia Butsashvili, Irma Kirtadze, Josephine G. Walker, Ketevan Stvilia, Lali Sharvadze, Francisco Averhoff, Tinatin Kuchuloria, Alexander Asatiani, Aaron G Lim, Mamuka Zakalashvili, Juliette Morgan, Hannah Fraser, David Otiashvili, Matthew Hickman, Shaun Shadaker, Mark H. Kuniholm, Irma Khonelidze

Publikováno v: The Lancet Global Health, Vol 8, Iss 2, Pp e244-e253 (2020)
Walker, J G, Fraser, H, Lim, A G, Hickman, M, Martin, N, Vickerman, P & al., E 2020, ' Interim impact evaluation of the hepatitis C elimination program in Georgia : a modelling study ', Lancet Global Health, vol. 8, no. 2, pp. PE244-E253 . https://doi.org/10.1016/S2214-109X(19)30483-8
The Lancet. Global Health

Summary Background Georgia has a high prevalence of hepatitis C, with 5·4% of adults chronically infected. On April 28, 2015, Georgia launched a national programme to eliminate hepatitis C by 2020 (90% reduction in prevalence) through scaled-up trea

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a84ff961a43b792277d84442f340226
https://pubmed.ncbi.nlm.nih.gov/31864918

SAT-222-Improvement in liver fibrosis among patients with hepatitis C who achieved sustained viral response after direct acting antivirals treatment, in country of Georgia

Autor: Lia Gvinjilia, David Metreveli, Francisco Averhoff, Muazzam Nasrullah, Mamuka Zakalashvili, Vakhtang Kerashvili, Tatia Kuchuloria, George Kamkamidze, Maia Butsashvili, Amiran Gamkrelidze, E Dolmazashvili

Publikováno v: Journal of Hepatology. 70:e727-e728

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::406d90adc1b0f6d35d3ec49c0be49e3d
https://doi.org/10.1016/s0618-8278(19)31455-0